Cargando…

Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study

BACKGROUND: Type 2 diabetes (T2D) is common and increasing in prevalence. It is possible to prevent or delay T2D using lifestyle intervention programmes. Entry to these programmes is usually determined by a measure of glycaemia in the ‘intermediate’ range. This paper investigated the relationship be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodgers, Lauren R., Hill, Anita V., Dennis, John M., Craig, Zoe, May, Benedict, Hattersley, Andrew T., McDonald, Timothy J., Andrews, Rob C., Jones, Angus, Shields, Beverley M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377980/ https://www.ncbi.nlm.nih.gov/pubmed/34412655 http://dx.doi.org/10.1186/s12916-021-02054-w

Ejemplares similares

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?
por: Jones, Angus G., et al.
Publicado: (2016)

What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study
por: McGovern, Andrew P., et al.
Publicado: (2019)

The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
por: Young, Katherine G., et al.
Publicado: (2022)

Correction to: The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
por: Young, Katherine G., et al.
Publicado: (2023)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study
por: Niwaha, Anxious J, et al.
Publicado: (2021)

Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control Studies
por: Steele, Anna M., et al.
Publicado: (2013)

Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA(1c) in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?
por: Marren, S. M., et al.
Publicado: (2019)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication
por: Tan, Xiao, et al.
Publicado: (2020)

Significantly High HbA(1c) in Diabetic Patient with Hb J: Case Report
por: Wan Nik, Wan Nor Fazila Hafizan, et al.
Publicado: (2022)

Association of Diabetes and HbA(1c) Levels With Gastrointestinal Manifestations
por: Tseng, Ping-Huei, et al.
Publicado: (2012)

An Emerging Diabetes Mellitus Diagnosis Modality: HbA(1c)
por: Seo, Hyun-Ae, et al.
Publicado: (2012)

The Utility of HbA1c as a Diagnostic Criterion of Diabetes
por: Kim, Hee-Jung, et al.
Publicado: (2011)

Glycated haemoglobin (HbA(1c)) for postmortem diagnosis of diabetes
por: Lepik, Delia, et al.
Publicado: (2018)

HbA1c and retinal sensitivity in diabetics using microperimetry
por: Sharanjeet-Kaur, et al.
Publicado: (2019)

Is HbA1c an ideal biomarker of well-controlled diabetes?
por: Kaiafa, Georgia, et al.
Publicado: (2020)

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
por: Thomas, Nicholas J., et al.
Publicado: (2019)

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years
por: Lynam, Anita, et al.
Publicado: (2019)

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)

The Effect of Anemia and the Goal of Optimal HbA1c Control in Diabetes and Non-Diabetes
por: Katwal, Prakash C, et al.
Publicado: (2020)

Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis
por: Conway, Rebecca Baqiyyah, et al.
Publicado: (2023)

Are the Same Clinical Risk Factors Relevant for Incident Diabetes Defined by Treatment, Fasting Plasma Glucose, and HbA(1c)?
por: Balkau, Beverley, et al.
Publicado: (2011)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

Effect of the different assays of HbA1c on diabetic patients monitoring
por: Razi, Farideh, et al.
Publicado: (2015)

Beyond HbA(1c): Environmental Risk Factors for Diabetic Retinopathy
por: Nwanyanwu, Kristen Harris, et al.
Publicado: (2015)

HbA(1c) and the Prediction of Type 2 Diabetes in Children and Adults
por: Vijayakumar, Pavithra, et al.
Publicado: (2017)

Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients
por: Sherwani, Shariq I., et al.
Publicado: (2016)

Spurious HbA1c results in patients with diabetes treated with dapsone
por: Aljenaee, Khaled, et al.
Publicado: (2019)

HbA1c changes in patients with diabetes following periodontal therapy
por: Kim, Su-Hwan, et al.
Publicado: (2021)

Misleading HbA1c Measurement in Diabetic Patients with Hemoglobin Variants
por: Mitchai, Manthana, et al.
Publicado: (2021)

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

HbA(1c) and Risk of Severe Hypoglycemia in Type 2 Diabetes: The Diabetes and Aging Study
por: Lipska, Kasia J., et al.
Publicado: (2013)

Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes
por: Ji, HaEun, et al.
Publicado: (2020)

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study
por: Barron, Emma, et al.
Publicado: (2020)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Validation of HbA1c as a diagnostic marker for diabetes in the critically ill
por: Gornik, I, et al.
Publicado: (2010)

Diabetes care: reasons for missing HbA(1c )measurements in general practice
por: Keuken, Debby G, et al.
Publicado: (2011)

Drug titration patterns and HbA(1c) levels in type 2 diabetes
por: Ross Maclean, J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_cf1ui3ipsti3c6rn59jr0p5olg